Our Licensing & Distribution Business Model
Our Business Model revolves around the facilitation of licensing & distribution arrangements between leading local and regional companies ("Licensees") and US/Europe/Japan-innovative based pharmaceutical/biotech/medical device companies ("Licensors").
The selected products are manufactured and shipped from the licensor’s plant in a fully finished form in return for an agreed supply price.
The Contribution of the companies in our network (Licensees)
The Contribution of the companies in our network (Licensees)
- Product Registration
- Trademark Registration
- Product Promotion
- Direct Selling
- Distribution
- Potential toll manufacturing/packaging (if required)
The Benefits for US, Europe and Japan-based Companies (Licensors)
The Benefits for US, Europe and Japan-based Companies (Licensors)
- Penetration into fast growing markets
- Effective approach to cultural barriers
- Proven model by multinational pharmaceutical companies
- Low cost of operation and avoidance of fixed costs
- Trusted network of partners
- Dealing with a one company ("one stop-shop") - The Harel Group
Global Markets represent an attractive business opportunity to innovative companies and the licensing and distribution business model has a proven track record.The Harel Group has formed a unique and trusted network of leading local and regional partners in the Emerging Markets that can add value in a relatively short time through a resource efficient process.